Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
BING NEWS:
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:32 pm | View Link
  • Vivus Wins FDA Approval
    MINYANVILLE ORIGINAL Vivus (VVUS) shareholders got a piece of good news late last week when the Food and Drug Administration approved the ... a decision on market clearance in April but the FDA delayed doing so until July 17. "The majority of the value ...
    04/30/2012 - 9:07 am | View Link
  • Vivus' Erectile Dysfunction Drug Stendra Wins FDA Approval
    Law360, New York (April 27, 2012, 8:00 PM ET) -- The U.S. Food and Drug Administration on Friday approved Vivus Inc.'s erectile dysfunction pill Stendra, the first erectile dysfunction treatment to be allowed for use in the U.S. in a decade and the first ...
    04/27/2012 - 1:00 pm | View Link
  • Vivus Obesity Pill Wins FDA Panel Nod; NeuroSearch Surges
    Trading in Vivus stock was halted yesterday before the FDA panel vote. NeuroSearch, which is developing tesofensine for obesity, climbed 5.6 percent to 17 kroner and Novo Nordisk, which is studying its Victoza diabetes drug as a weight-loss treatment ...
    02/22/2012 - 11:00 am | View Link
  • UPDATE 3-Shares of Vivus up on U.S. FDA review of diet drug
    If Qnexa wins the FDA's seal of approval, analysts estimate it could take ... surge ahead of what could be a major product for the company since its only other U.S. drug was approved in 1996. Rivals are also eyeing the impact of Vivus' review on their ...
    07/13/2010 - 8:56 am | View Link
  • More
BING SEARCH:
  • DRUG SPENDING:
    The rising cost of specialty drugs continues to be a battleground between drugmakers, healthcare providers, and payers over the cost of innovative therapies.
    08/22/2014 - 7:12 am | View Website
  • Phentermine News, Photos and Videos
    first new diet drug approved in a decade. The FDA is expected to make a decision on Qnexa -- a low-dose combination of phentermine and topiramate -- in July.
    08/22/2014 - 4:56 am | View Website
  • Breaking News – RTTNews
    Get the latest Breaking News, headlines, business news and more on RTTNews.com
    08/21/2014 - 11:34 pm | View Website
  • BioWorld | The Daily Biopharmaceutical News Source
    Contains business, science, and regulatory news, including mergers and collaborations, FDA hearings and results, and research breakthroughs. Need subscription to use.
    08/21/2014 - 8:14 pm | View Website
  • VVUS
    Up to date analysis of Vivus, Inc. (VVUS) and its stock by hedge fund managers and industry experts. Find out what Vivus, Inc. is saying about its business from the ...
    08/21/2014 - 7:21 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News